| Primary information |
|---|
| ID | antitb_1432 |
| Peptide Name | Viomycin |
| Sequence | H2N-CH-CH-CH-CH-R1-CH-NH2-Ch-CO-Nh-C-CO-NH-CH2OH-CO-NH-CH(CH2OH)-CO-NH-R2-CO-R3-HN-CH |
| N-terminal Modification | Free |
| C-terminal Modification | Free |
| Chemical Modification | R1=H, R2= >C=CHNHCONH2, R3=Tbd (Tuberactin) |
| Linear/ Cyclic | NA |
| Length | 38 |
| Chirality | NA |
| Nature | NA |
| Source | NA |
| Origin | NA |
| Species | Mycobacterium tuberculosis |
| Strain | Mycobacterium tuberculosis 607 |
| Inhibition Concentartion | MIC = 1.6 μg/ml |
| In vitro/In vivo | in vitro |
| Cell Line | NA |
| Inhibition Concentartion | NA |
| Cytotoxicity | NA |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Response | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other Activities | Antibacterial against Bacillus subtilis, Pseudomonas aeruginosa, proteus vulgaris, satphylococus aureous |
| Pubmed ID | 197067 |
| Year of Publication | 1977 |
| 3-D Structure | NA |